Lit AP Tablet is a combination medication containing Ambroxol (60mg), Levocetirizine (5mg), Paracetamol (350mg), and Phenylephrine (5mg), formulated for the symptomatic relief of respiratory tract conditions accompanied by cough, nasal congestion, and allergic manifestations. Ambroxol acts as a mucolytic agent, facilitating the breakdown and clearance of mucus, thereby improving airway patency. Levocetirizine, a selective second-generation antihistamine, provides effective relief from allergic symptoms such as rhinorrhea, sneezing, and nasal itching by antagonizing peripheral H1 receptors. Paracetamol serves as an analgesic and antipyretic, reducing fever and alleviating mild to moderate pain associated with upper respiratory infections. Phenylephrine, a selective alpha-1 adrenergic receptor agonist, exerts vasoconstrictive effects on nasal mucosa, leading to decreased nasal congestion and improved breathing. The synergistic action of these components makes Lit AP Tablet suitable for managing conditions like acute bronchitis, allergic rhinitis, and common cold symptoms. It is recommended to use this medication under medical supervision, considering contraindications such as hypertension, hypersensitivity, and certain cardiovascular disorders. Dosage adjustments may be necessary in hepatic or renal impairment. Adverse effects may include drowsiness, dry mouth, gastrointestinal disturbances, and increased blood pressure. Patients should adhere to prescribed dosages and consult healthcare providers if symptoms persist.